Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
Journal of Cancer Research and Clinical Oncology
|
August 7, 2019
Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer
Sabine Heublein, Michael S Anglesio, Frederik Marmé, et al.
Journal of Cancer Research and Clinical Oncology
|
March 4, 2016
p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Sabine Heublein, Sabina K Page, Doris Mayr, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 22, 2017
Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
Sabine Heublein, Doris Mayr, Alfons Meindl, et al.
BMC Research Notes
|
October 6, 2012
Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
Christoph Scholz, Sabine Heublein, Miriam Lenhard, et al.
Archives of Gynecology and Obstetrics
|
July 19, 2022
How to make students satisfied with digital teaching? Investigative results from teaching evaluations in Gynecology and Obstetrics
Steffen Tietz, Laura Bodenbeck, Fabian Riedel, et al.
Histology and Histopathology
|
November 23, 2013
Significance of the tumor protease cathepsin D for the biology of breast cancer
Darius Dian, Sabine Heublein, Irmi Wiest, et al.
Plos One
|
June 2, 2015
Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways
Sabine Heublein, Doris Mayr, Alfons Meindl, et al.
Journal of Ovarian Research
|
January 24, 2013
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
Sabine Heublein, Thomas Vrekoussis, Doris Mayr, et al.
Anticancer Research
|
February 11, 2014
ESR1 promoter methylation in squamous cell cervical cancer
Verena Kirn, Ivanka Zaharieva, Sabine Heublein, et al.
Plos One
|
August 17, 2013
The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients
Sabine Heublein, Doris Mayr, Thomas Vrekoussis, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
Journal of Cancer Research and Clinical Oncology
|
August 7, 2019
Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer
Sabine Heublein, Michael S Anglesio, Frederik Marmé, et al.
Journal of Cancer Research and Clinical Oncology
|
March 4, 2016
p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Sabine Heublein, Sabina K Page, Doris Mayr, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 22, 2017
Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
Sabine Heublein, Doris Mayr, Alfons Meindl, et al.
BMC Research Notes
|
October 6, 2012
Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
Christoph Scholz, Sabine Heublein, Miriam Lenhard, et al.
Archives of Gynecology and Obstetrics
|
July 19, 2022
How to make students satisfied with digital teaching? Investigative results from teaching evaluations in Gynecology and Obstetrics
Steffen Tietz, Laura Bodenbeck, Fabian Riedel, et al.
Histology and Histopathology
|
November 23, 2013
Significance of the tumor protease cathepsin D for the biology of breast cancer
Darius Dian, Sabine Heublein, Irmi Wiest, et al.
Plos One
|
June 2, 2015
Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways
Sabine Heublein, Doris Mayr, Alfons Meindl, et al.
Journal of Ovarian Research
|
January 24, 2013
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
Sabine Heublein, Thomas Vrekoussis, Doris Mayr, et al.
Anticancer Research
|
February 11, 2014
ESR1 promoter methylation in squamous cell cervical cancer
Verena Kirn, Ivanka Zaharieva, Sabine Heublein, et al.
Plos One
|
August 17, 2013
The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients
Sabine Heublein, Doris Mayr, Thomas Vrekoussis, et al.
Page
of 9